BD GENERICS ApS: Financial statements 2023
CVR: 28707207
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
BD GENERICS ApS (CVR 28707207) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -101,176 and a net result of DKK -64,095 compared with DKK -43,869 the year before. Equity in the 2023 report amounted to DKK 764,154. The solvency ratio was 80.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK -101,176
- Profit/Loss
- DKK -64,095
- Equity
- DKK 764,154
- Total Assets
- DKK 946,690
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -101 t. | -64 t. | 764 t. | - |
| 2022 | 0 | -70 t. | -44 t. | 828 t. | - |
| 2021 | 0 | -7 t. | -13 t. | 872 t. | - |
| 2020 | - | -9 t. | -14 t. | 885 t. | - |
| 2019 | - | -7 t. | -10 t. | 899 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BD GENERICS ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -43,869.
About BD GENERICS ApS
BD GENERICS ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2005. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Gerner Jacobsen. The company is owned by TGJ HOLDING ApS. The company has 1 employee (2009). In 2025, the company reported a gross profit of DKK -117,586 and a net result of DKK -64,678 compared with DKK -61,196 the year before. Equity in the 2025 report amounted to DKK 638,280.